Jeffrey M. Drazen MD
Adjunct Professor, Pulmonary, Allergy, Sleep & Critical Care Medicine
jdrazen@nejm.org

Sections
Pulmonary, Allergy, Sleep & Critical Care Medicine
Biography
Jeffrey M. Drazen, M.D., joined the New England Journal of Medicine (NEJM) as editor-in-chief in July of 2000. At NEJM, Dr. Drazen’s responsibilities include oversight of all editorial content and policies. His editorial background includes service as an associate editor or editorial board member for the Journal of Clinical Investigation, the American Journal of Respiratory Cell and Molecular Biology, and the American Journal of Medicine.
A specialist in pulmonology, Dr. Drazen maintains an active research program. Dr. Drazen has published hundreds of articles on topics such as lung physiology and the mechanisms involved in asthma. In 1999, he delivered the Amberson Lecture, the major research address at the annual meeting of the American Thoracic Society. In 2000, he received the Chadwick Medal from the Massachusetts Thoracic Society for his contributions to the study of lung disease.
Dr. Drazen is the Distinguished Parker B. Francis Professor of Medicine at Harvard Medical School, professor of physiology at the Harvard School of Public Health, senior physician at Brigham and Women’s Hospital, and adjunct professor of medicine at the Chobanian and Avedisian School of Medicine. In 2003, he was elected as a member of the Institute of Medicine. Dr. Drazen has served on numerous committees for the National Institutes of Health, including the Respiratory and Applied Physiology Study Section; the Lung Biology and Pathology Study Section; the Pulmonary Disease Advisory Council; the National Heart, Lung, and Blood Institute Advisory Council; the Public Access Working Group; and the National Heart, Lung, and Blood Institute’s Division of Lung Disease Executive Planning Committee. He has also served on the Veterans’ Administration National Research Advisory Committee. He currently serves on the Global Initiative for Asthma Science Committee, the World Health Organization’s Scientific Advisory Group on Clinical Trials Registration, and co-chairs the Institute of Medicine’s Forum on Drug Discovery, Development, and Translation.
Dr. Drazen earned his bachelor’s degree and graduated summa cum laude from Tufts University. He received his medical degree from Harvard Medical School and completed his internship and residency at Peter Bent Brigham Hospital in Boston. Dr. Drazen has received honorary degrees from the University of Ferrara, Italy, and the National and Kapodistrian University of Athens, Greece.
A native of Missouri, Dr. Drazen lives with his wife in Winchester, Massachusetts. They are the parents of two grown sons.
Education
MD, Harvard Medical School, 1972
BS, Tufts University, 1968
Publications
Beam AL, Drazen JM, Kohane IS, Leong TY, Manrai AK, Rubin EJ. Artificial Intelligence in Medicine. N Engl J Med. 2023 Mar 30; 388(13):1220-1221. PMID: 36988598.
Published on 3/30/2023Beam AL, Drazen JM, Kohane IS, Leong TY, Manrai AK, Rubin EJ. Artificial Intelligence in Medicine. N Engl J Med. 2023 Mar 30; 388(13):1220-1221. PMID: 36988598.
Published on 3/30/2023Haug CJ, Drazen JM. Artificial Intelligence and Machine Learning in Clinical Medicine, 2023. N Engl J Med. 2023 Mar 30; 388(13):1201-1208. PMID: 36988595.
Published on 3/30/2023Haug CJ, Drazen JM. Artificial Intelligence and Machine Learning in Clinical Medicine, 2023. N Engl J Med. 2023 Mar 30; 388(13):1201-1208. PMID: 36988595.
Published on 2/8/2023Levy ML, Bacharier LB, Bateman E, Boulet LP, Brightling C, Buhl R, Brusselle G, Cruz AA, Drazen JM, Duijts L, Fleming L, Inoue H, Ko FWS, Krishnan JA, Mortimer K, Pitrez PM, Sheikh A, Yorgancioglu A, Reddel HK. Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update. NPJ Prim Care Respir Med. 2023 Feb 08; 33(1):7. PMID: 36754956.
Published on 4/6/2022Abdulnour RE, Parsons AS, Muller D, Drazen J, Rubin EJ, Rencic J. Deliberate Practice at the Virtual Bedside to Improve Clinical Reasoning. N Engl J Med. 2022 05 19; 386(20):1946-1947. PMID: 35385627.
Published on 1/10/2022Sacks CA, Hardin CC, Normand SL, Kadire S, Takvorian K, Galloway N, Linga R, Hannon P, Drazen J, Rubin E. NEJM Evidence - A New Journal in the NEJM Group Family. N Engl J Med. 2022 01 13; 386(2):182-183. PMID: 35007414.
Published on 1/1/2022Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, Cruz AA, Duijts L, Drazen JM, FitzGerald JM, Fleming LJ, Inoue H, Ko FW, Krishnan JA, Levy ML, Lin J, Mortimer K, Pitrez PM, Sheikh A, Yorgancioglu AA, Boulet LP. Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes. Respirology. 2022 01; 27(1):14-35. PMID: 34668278.
Published on 1/1/2022Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, Cruz AA, Duijts L, Drazen JM, FitzGerald JM, Fleming LJ, Inoue H, Ko FW, Krishnan JA, Levy ML, Lin J, Mortimer K, Pitrez PM, Sheikh A, Yorgancioglu AA, Boulet LP. Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes. Am J Respir Crit Care Med. 2022 01 01; 205(1):17-35. PMID: 34658302.
Published on 12/31/2021Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, Cruz AA, Duijts L, Drazen JM, FitzGerald JM, Fleming LJ, Inoue H, Ko FW, Krishnan JA, Levy ML, Lin J, Mortimer K, Pitrez PM, Sheikh A, Yorgancioglu AA, Boulet LP. Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes. Eur Respir J. 2022 Jan; 59(1). PMID: 34667060.